Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01298037 · ClinicalTrials.gov registry record
HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B
A clinical trial of Hepatitis B, sponsored by University of Pennsylvania.
- Active
- Registry status
- 201
- Enrollment target
- 12
- Study locations
NCT01298037 is a study of Hepatitis B that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 201 participants, below the 1,622-participant average among 32 other Hepatitis B trials with a reported enrollment target (88% lower). The trial reports 12 study locations across 8 states.
The verdict
NCT01298037, a study of Hepatitis B, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- 201 participants
- Enrollment target
- 12
- Study locations
Study Summary
This is an ancillary to the NIDDK-sponsored Hepatitis B Research Network (HBRN) Study Cohort Study NCT01263587. This study will examine the balance between immune regulatory and effector responses in hepatitis B-infected participants enrolled in the HBRN study (NCT01263587).
Conditions Studied
Study Locations (12)
California
- California Pacific Medical Center - San Francisco
- University of California San Francisco Medical Center - San Francisco
Massachusetts
- Massachusetts General Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Minnesota
- University of Minnesota - Plymouth
- Mayo Clinic Rochester - Rochester
Washington
- Virginia Mason Medical Center - Seattle
- Harborview Medical Center - Seattle
North Carolina
- University of North Carolina - Chapel Hill
Texas
- University of Texas Southwestern - Dallas
Virginia
- Virginia Commonwealth University - Richmond
Ontario
- University of Toronto - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2011-02-01 |
| Est. Completion | 2026-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01298037
The ClinicalTrials.gov registry entry for NCT01298037 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,622-participant average among 32 other Hepatitis B trials with a reported enrollment target (88% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hepatitis B appearing as the primary indexed condition, and to 0 interventions.
NCT01298037 reports 12 study locations spanning 8 distinct geographic areas - top geographies include California, Massachusetts, Minnesota.
Frequently Asked Questions
What is clinical trial NCT01298037 about?
NCT01298037 is a clinical study titled "HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B". This is an ancillary to the NIDDK-sponsored Hepatitis B Research Network (HBRN) Study Cohort Study NCT01263587. This study will examine the balance between immune regulatory and effector responses in hepatitis B-infected participants enrolled in the HBRN study (NCT01263587).
What is the current status of trial NCT01298037?
This trial is currently active not recruiting. The enrollment target is 201 participants. The study started on 2011-02-01. Estimated completion is 2026-12-01.
What conditions does trial NCT01298037 study?
This clinical trial studies the following conditions: Hepatitis B.
Who is sponsoring clinical trial NCT01298037?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01298037 being conducted?
This trial has 12 study locations across California, Massachusetts, Minnesota, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis B
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Patients With Liver Disease
RECRUITING
-
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
RECRUITING · Phase 4
-
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
RECRUITING · Phase 2
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
RECRUITING · Phase 4
-
A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.